SPL Set ID: e1ab38bf-cfd0-444f-a8a6-bb8588b63228

1 drug(s) with this SPL Set ID

Open DailyMed details

Regadenoson REGADENOSON
0.4 mg/5 ml Injection
MYLAN INSTITUTIONAL LLC FDA Rx Only

Regadenoson is an A 2A adenosine receptor agonist that is a coronary vasodilator [see Clinical Pharmacology (12.1) ] . Regadenoson is chemically described as adenosine, 2-[4-[(methylamino)carbonyl]-1 H -pyrazol-1-yl]-, hemihydrate. Its structural formula is: The molecular formula for regadenoson hemihydrate is C 15 H 18 N 8 O 5 • ½H 2 O and its molecular weight is 399.35. Regadenoson is a sterile, nonpyrogenic solution for intravenous injection. The solution is clear and colorless. Each 1 mL in the 5 mL pre-filled syringe contains 0.082 mg of regadenoson hemihydrate, corresponding to 0.08 mg regadenoson on an anhydrous basis, 10.9 mg dibasic sodium phosphate dihydrate, 5.4 mg monobasic sodium phosphate monohydrate, 150 mg propylene glycol, 1 mg edetate disodium dihydrate, and Water for Injection, with pH between 6.3 and 7.7. Regadenoson Structural Formula

← Back to search